• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肾衰竭的功能不需要p53稳定或Mdm2重新定位。

ARF function does not require p53 stabilization or Mdm2 relocalization.

作者信息

Korgaonkar Chandrashekhar, Zhao Lili, Modestou Modestos, Quelle Dawn E

机构信息

Department of Pharmacology. Molecular Biology Graduate Program, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.

出版信息

Mol Cell Biol. 2002 Jan;22(1):196-206. doi: 10.1128/MCB.22.1.196-206.2002.

DOI:10.1128/MCB.22.1.196-206.2002
PMID:11739734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC134207/
Abstract

It is generally accepted that the ARF tumor suppressor induces p53-dependent growth arrest by sequestering the p53 antagonist Mdm2 in the nucleolus. Previous mutagenic studies of murine ARF suggested that residues 1 through 14 and 26 through 37 were critical for Mdm2 binding, while the latter domain also governed ARF nucleolar localization. We show that mouse ARF residues 6 to 10 and 21 to 25 are required for ARF-induced growth arrest whereas residues 1 to 5 and 29 to 34 are dispensable. Deletion of the putative nucleolar localization signal (31)RRPR(34) did not prevent nucleolar localization. Surprisingly, unlike wild-type ARF, growth-inhibitory mutants D1-5 and D29-34 failed to stabilize p53 yet induced its transcriptional activation in reporter assays. This suggests that p53 stabilization is not essential for ARF-mediated activation of p53. Like wild-type ARF, both mutants also exhibited p53-independent function since they were able to arrest p53/Mdm2-null cells. Notably, other mutants lacking conserved residues 6 to 10 or 21 to 25 were unable to suppress growth in p53-positive cells despite nucleolar localization and the ability to import Mdm2. Those observations stood in apparent contrast to the ability of wild-type ARF to block growth in some cells without relocalizing endogenous Mdm2 to nucleoli. Together, these data show a lack of correlation between ARF activity and Mdm2 relocalization, suggesting that additional events other than Mdm2 import are required for ARF function.

摘要

一般认为,ARF肿瘤抑制因子通过将p53拮抗剂Mdm2隔离在核仁中来诱导p53依赖的生长停滞。先前对小鼠ARF的诱变研究表明,第1至14位和第26至37位残基对Mdm2结合至关重要,而后一个结构域也决定了ARF的核仁定位。我们发现,小鼠ARF的第6至10位和第21至25位残基是ARF诱导生长停滞所必需的,而第1至5位和第29至34位残基则是可有可无的。删除假定的核仁定位信号(31)RRPR(34)并不妨碍核仁定位。令人惊讶的是,与野生型ARF不同,生长抑制突变体D1-5和D29-34未能稳定p53,但在报告基因检测中诱导了其转录激活。这表明p53稳定化对于ARF介导的p53激活并非必不可少。与野生型ARF一样,这两个突变体也表现出p53非依赖性功能,因为它们能够使p53/Mdm2缺失细胞停滞生长。值得注意的是,其他缺乏保守的第6至10位或第21至25位残基的突变体,尽管具有核仁定位和导入Mdm2的能力,但仍无法抑制p53阳性细胞的生长。这些观察结果与野生型ARF在某些细胞中阻止生长而不将内源性Mdm2重新定位到核仁的能力形成明显对比。总之,这些数据表明ARF活性与Mdm2重新定位之间缺乏相关性,这表明ARF功能需要除Mdm2导入之外的其他事件。

相似文献

1
ARF function does not require p53 stabilization or Mdm2 relocalization.急性肾衰竭的功能不需要p53稳定或Mdm2重新定位。
Mol Cell Biol. 2002 Jan;22(1):196-206. doi: 10.1128/MCB.22.1.196-206.2002.
2
Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.调控ARF-mdm2相互作用及该复合物核仁定位的协同信号。
Mol Cell Biol. 2000 Apr;20(7):2517-28. doi: 10.1128/MCB.20.7.2517-2528.2000.
3
Sumoylation induced by the Arf tumor suppressor: a p53-independent function.由Arf肿瘤抑制因子诱导的类泛素化修饰:一种不依赖p53的功能
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7689-94. doi: 10.1073/pnas.0502978102. Epub 2005 May 16.
4
Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.核仁Arf肿瘤抑制因子抑制核糖体RNA加工。
Mol Cell. 2003 Feb;11(2):415-24. doi: 10.1016/s1097-2765(03)00057-1.
5
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.核磷蛋白(B23)将ARF靶向核仁并抑制其功能。
Mol Cell Biol. 2005 Feb;25(4):1258-71. doi: 10.1128/MCB.25.4.1258-1271.2005.
6
PML regulates p53 stability by sequestering Mdm2 to the nucleolus.早幼粒细胞白血病蛋白通过将小鼠双微体2蛋白隔离在核仁中来调节p53的稳定性。
Nat Cell Biol. 2004 Jul;6(7):665-72. doi: 10.1038/ncb1147. Epub 2004 Jun 13.
7
ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.急性肾衰竭在一种对小鼠双微体2敏感的肿瘤抑制途径中阻碍核仁磷酸蛋白/B23穿梭。
Mol Cell Biol. 2004 Nov;24(21):9327-38. doi: 10.1128/MCB.24.21.9327-9338.2004.
8
p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.p14ARF是正常人成纤维细胞受到电离辐射后p53反应的一个组成部分。
Oncogene. 2004 Aug 12;23(36):6040-6. doi: 10.1038/sj.onc.1207824.
9
Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.p14ARF对p53的稳定作用,而不伴有MDM2重新定位于核仁。
Nat Cell Biol. 2001 May;3(5):445-52. doi: 10.1038/35074506.
10
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.ARF肿瘤抑制因子与p53和Mdm2的功能及物理相互作用。
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8292-7. doi: 10.1073/pnas.95.14.8292.

引用本文的文献

1
Farnesoid X receptor functions in cervical cancer via the p14-mouse double minute 2-p53 pathway.法尼醇 X 受体通过 p14-mouse 双微体 2-p53 通路在宫颈癌中发挥作用。
Mol Biol Rep. 2022 May;49(5):3617-3625. doi: 10.1007/s11033-022-07201-x. Epub 2022 Mar 28.
2
It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy.情况愈发复杂——重新审视肿瘤发生与癌症治疗中的p53-MDM2-ARF三角关系
Front Cell Dev Biol. 2022 Jan 26;10:818744. doi: 10.3389/fcell.2022.818744. eCollection 2022.
3
MYC Oncogene Contributions to Release of Cell Cycle Brakes.MYC 癌基因对细胞周期刹车的释放作用。
Genes (Basel). 2019 Mar 22;10(3):244. doi: 10.3390/genes10030244.
4
Dual Role of the Alternative Reading Frame ARF Protein in Cancer.交替阅读框 ARF 蛋白在癌症中的双重作用。
Biomolecules. 2019 Mar 4;9(3):87. doi: 10.3390/biom9030087.
5
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.RABL6A 通过抑制抑瘤性的 PP2A/AKT 信号通路促进胰腺神经内分泌肿瘤的生长。
J Clin Invest. 2019 Mar 4;129(4):1641-1653. doi: 10.1172/JCI123049.
6
Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways.核仁衍生介质在致癌应激反应及p53依赖途径激活中的作用
Histochem Cell Biol. 2016 Aug;146(2):119-39. doi: 10.1007/s00418-016-1443-6. Epub 2016 May 3.
7
MDM2-mediated degradation of p14ARF: a novel mechanism to control ARF levels in cancer cells.MDM2介导的p14ARF降解:一种控制癌细胞中ARF水平的新机制。
PLoS One. 2015 Feb 27;10(2):e0117252. doi: 10.1371/journal.pone.0117252. eCollection 2015.
8
RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner.RABL6A以Rb1依赖的方式促进G1-S期进程和胰腺神经内分泌肿瘤细胞增殖。
Cancer Res. 2014 Nov 15;74(22):6661-70. doi: 10.1158/0008-5472.CAN-13-3742. Epub 2014 Oct 1.
9
The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B.ARF肿瘤抑制因子通过调控Aurora B来防止染色体不稳定并确保有丝分裂检查点的保真度。
Mol Biol Cell. 2014 Sep 15;25(18):2761-73. doi: 10.1091/mbc.E14-05-0966. Epub 2014 Jul 23.
10
p53 is positively regulated by miR-542-3p.p53受miR-542-3p正向调控。
Cancer Res. 2014 Jun 15;74(12):3218-27. doi: 10.1158/0008-5472.CAN-13-1706. Epub 2014 Apr 24.

本文引用的文献

1
Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.p14ARF对p53的稳定作用,而不伴有MDM2重新定位于核仁。
Nat Cell Biol. 2001 May;3(5):445-52. doi: 10.1038/35074506.
2
Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein.p19Arf肿瘤抑制蛋白p53调控结构域的溶液结构
Biochemistry. 2001 Feb 27;40(8):2379-86. doi: 10.1021/bi0024005.
3
Human ARF binds E2F1 and inhibits its transcriptional activity.人类ARF与E2F1结合并抑制其转录活性。
Oncogene. 2001 Mar 1;20(9):1033-41. doi: 10.1038/sj.onc.1204220.
4
Human ARF protein interacts with topoisomerase I and stimulates its activity.人类ARF蛋白与拓扑异构酶I相互作用并刺激其活性。
Oncogene. 2001 Feb 15;20(7):836-48. doi: 10.1038/sj.onc.1204170.
5
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.致癌性Ras激活ARF-p53通路以抑制上皮细胞转化。
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5025-30. doi: 10.1073/pnas.091100298. Epub 2001 Apr 17.
6
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation.MdmX与ARF的结合会影响Mdm2蛋白的稳定性和p53的反式激活。
J Biol Chem. 2001 Jul 6;276(27):25336-41. doi: 10.1074/jbc.M010685200. Epub 2001 Apr 10.
7
The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein.人类肿瘤抑制因子arf与亲嗜素/神经连接蛋白II相互作用,后者是一种与1型蛋白磷酸酶结合的蛋白。
J Biol Chem. 2001 Apr 27;276(17):14161-9. doi: 10.1074/jbc.M006845200. Epub 2001 Jan 30.
8
p19ARF targets certain E2F species for degradation.p19ARF靶向某些E2F蛋白进行降解。
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4455-60. doi: 10.1073/pnas.081061398. Epub 2001 Mar 27.
9
Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway.Pex19p抑制p19ARF-p53-p21WAF1肿瘤抑制通路。
J Biol Chem. 2001 Jun 1;276(22):18649-52. doi: 10.1074/jbc.C100011200. Epub 2001 Mar 19.
10
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.p300/CBP介导的p53乙酰化通常由p53激活剂诱导,并被MDM2抑制。
EMBO J. 2001 Mar 15;20(6):1331-40. doi: 10.1093/emboj/20.6.1331.